Ken Griffin Vaxart, Inc. Transaction History

Citadel Advisors LLC

$550 Billion
Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Vaxart, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 50,300 shares of VXRT stock, worth $19,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,300

Previous 14,300 251.75%

Holding current value

$19,114

Previous $5,000 340.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.54 - $0.86 $270,876 - $431,395	501,623 New	501,623 $331,000
Q1 2024 May 15, 2024	BUY	$0.56 - $1.41 $151,451 - $381,333	270,449 Added 54.2%	769,467 $1 Million
Q4 2023 Feb 14, 2024	BUY	$0.57 - $0.85 $281,594 - $419,922	494,026 Added 9896.35%	499,018 $284,000
Q3 2023 Nov 14, 2023	SELL	$0.69 - $0.85 $513,837 - $632,988	-744,692 Reduced 99.33%	4,992 $3,000
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.41 $162,080 - $380,888	270,134 Added 56.33%	749,684 $547,000
Q1 2023 May 15, 2023	SELL	$0.71 - $1.25 $1.39 Million - $2.45 Million	-1,960,812 Reduced 80.35%	479,550 $364,000
Q4 2022 Feb 14, 2023	BUY	$0.75 - $2.24 $748,729 - $2.24 Million	998,306 Added 69.23%	2,440,362 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $1.25 Million - $2.7 Million	599,421 Added 71.14%	1,442,056 $3.14 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $1.92 Million - $3.75 Million	710,626 Added 538.32%	842,635 $2.95 Million
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $112,359 - $173,908	-26,191 Reduced 16.56%	132,009 $665,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $272,499 - $375,926	47,227 Added 42.56%	158,200 $991,000
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $2.58 Million - $3.8 Million	-387,310 Reduced 77.73%	110,973 $882,000
Q1 2021 May 17, 2021	BUY	$5.64 - $23.33 $2.4 Million - $9.91 Million	424,791 Added 578.01%	498,283 $3.02 Million
Q4 2020 Feb 16, 2021	SELL	$3.5 - $7.98 $513,404 - $1.17 Million	-146,687 Reduced 66.62%	73,492 $420,000
Q3 2020 Nov 16, 2020	SELL	$4.78 - $16.97 $13.8 Million - $48.8 Million	-2,876,785 Reduced 92.89%	220,179 $1.46 Million
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $5.2 Million - $27.4 Million	3,096,964 New	3,096,964 $27.4 Million
Q4 2019 Feb 14, 2020	SELL	$0.28 - $0.39 $24,141 - $33,626	-86,221 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.3 - $0.75 $22,061 - $55,153	73,538 Added 579.82%	86,221 $31,000
Q3 2018 Nov 13, 2018	BUY	$2.42 - $3.29 $30,692 - $41,727	12,683 New	12,683 $0

Others Institutions Holding VXRT

# of Institutions

105

Shares Held

23.1M

Call Options Held

50.3K

Put Options Held

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $48.1M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account